A. Guillouzo and C. Guguen-guillouzo, toxicology, Expert Opinion on Drug Metabolism & Toxicology, vol.114, issue.10, pp.1279-1294, 2008.
DOI : 10.1126/science.1151526
URL : https://hal.archives-ouvertes.fr/hal-00742183

S. Wilkening, F. Stahl, and A. Bader, COMPARISON OF PRIMARY HUMAN HEPATOCYTES AND HEPATOMA CELL LINE HEPG2 WITH REGARD TO THEIR BIOTRANSFORMATION PROPERTIES, Drug Metabolism and Disposition, vol.31, issue.8, pp.31-1035, 2003.
DOI : 10.1124/dmd.31.8.1035

R. Jover, R. Bort, M. J. Gomez-lechon, and J. V. Castell, Re-expression of C/EBP?? induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells, FEBS Letters, vol.14, issue.2, pp.227-230, 1998.
DOI : 10.1016/S0014-5793(98)00746-7

P. Gripon, S. Rumin, S. Urban, L. Seyec, and J. , Nonlinear partial differential equations and applications: Infection of a human hepatoma cell line by hepatitis B virus, Proceedings of the National Academy of Sciences, vol.99, issue.24, pp.15655-60, 2002.
DOI : 10.1073/pnas.232137699

C. Aninat, A. Piton, D. Glaise, L. Charpentier, and T. , EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS, Drug Metabolism and Disposition, vol.34, issue.1, pp.75-83, 2006.
DOI : 10.1124/dmd.105.006759
URL : https://hal.archives-ouvertes.fr/hal-00702085

K. P. Kanebratt and T. B. Andersson, Evaluation of HepaRG Cells as an in Vitro Model for Human Drug Metabolism Studies, Drug Metabolism and Disposition, vol.36, issue.7, pp.1444-52, 2008.
DOI : 10.1124/dmd.107.020016

V. Cerec, D. Glaise, D. Garnier, and S. Morosan, Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor, Hepatology, vol.103, issue.4, pp.957-67, 2007.
DOI : 10.1002/hep.21536
URL : https://hal.archives-ouvertes.fr/hal-00690471